SCHEMBL9833014

SCHEMBL9833014

CCC1C(=O)Nc2cc3c(cc21)NC(NC(C)=O)N3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 3/20 0.41
PGR P06401 1/20 0.40
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
ALDH1A1 P00352 5/20 0.35
MAPT P10636 4/20 0.33
GAA P10253 3/20 0.33
CDYL2 Q8N8U2 1/20 0.32
CDYL Q9Y232 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
TP53 P04637 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
USP2 O75604 1/20 0.31
HPGD P15428 1/20 0.30
ALOX15 P16050 1/20 0.30
HSD17B10 Q99714 1/20 0.30
TNKS O95271 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9833830 0.83 ALDH1A1 (0.37) NQO2PGRIDO1TDO2ALDH1A1
SCHEMBL9834779 0.74 PGR (0.47) NQO2PGRIDO1ALDH1A1MAPT
SCHEMBL9836085 0.74 PGR (0.44) NQO2PGRIDO1MAPTGAA
SCHEMBL9834612 0.72 PGR (0.43) NQO2PGRMAPTTP53
SCHEMBL9834376 0.70 PGR (0.47) PGRIDO1TDO2ALDH1A1MAPT
SCHEMBL9834460 0.69 ATAD2 (0.42) PGR
SCHEMBL10568359 0.68 PGR (0.39) PGRMAPTTP53
SCHEMBL10821662 0.67 PGR (0.52) PGRIDO1MAPTGAACDYL2
SCHEMBL10373116 0.67 TP53 (0.41) PGRALDH1A1MAPTGAACDYL2
SCHEMBL10569328 0.67 PGR (0.41) NQO2PGRALDH1A1MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0214592-B1 PYRROLOBENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE PRODUCTS Roche Diagnostics GmbH (DE) 1991-08-14 EP disclosed
US-4730003-A Tricyclic compounds for treating heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1988-03-08 US disclosed